OBJECTIVE: Women with type 2 diabetes mellitus (T2DM) have a higher risk of fractures despite increased bone mineral density (BMD) as compared to women without diabetes. We hypothesized that bone strength is diminished in women with T2DM after accounting for lean body mass, which may contribute to their increased fracture risk. METHODS: Participants from Women's Health Initiative Observational Study were included in this cross-sectional study. These analyses include 3 groups of women: 1) T2DM women on diet or oral hypoglycemic agents (n=299); 2) T2DM women on insulin therapy (with or without oral agents) (n=128); and 3) Non-diabetic control women (n=5497). Hip structural analyses were done using the validated Beck's method on hip scans from dual energy x-ray absorptiometry (DXA). We compared BMD and section modulus (bending strength) at the narrow neck with and without correcting for total body DXA lean body mass. RESULTS: Women in all three groups were of similar ages (63.7, 64.6 and 64.2 years, respectively) and heights, but those with T2DM were heavier, with greater lean body weight vs controls (P<.001). In both diabetic groups, absolute BMD and section modulus were higher compared with controls. However, after adjusting for total lean body weight, diabetic women on insulin had significantly lower BMD and section modulus. CONCLUSION: Adjusted for lean body weight, the BMD and bending strength in the femoral neck are significantly lower in insulin-treated diabetic women vs controls. This may represent altered adaptation of bone modeling and explain the higher fracture risk in patients with T2DM.
OBJECTIVE:Women with type 2 diabetes mellitus (T2DM) have a higher risk of fractures despite increased bone mineral density (BMD) as compared to women without diabetes. We hypothesized that bone strength is diminished in women with T2DM after accounting for lean body mass, which may contribute to their increased fracture risk. METHODS:Participants from Women's Health Initiative Observational Study were included in this cross-sectional study. These analyses include 3 groups of women: 1) T2DM women on diet or oral hypoglycemic agents (n=299); 2) T2DM women on insulin therapy (with or without oral agents) (n=128); and 3) Non-diabetic control women (n=5497). Hip structural analyses were done using the validated Beck's method on hip scans from dual energy x-ray absorptiometry (DXA). We compared BMD and section modulus (bending strength) at the narrow neck with and without correcting for total body DXA lean body mass. RESULTS:Women in all three groups were of similar ages (63.7, 64.6 and 64.2 years, respectively) and heights, but those with T2DM were heavier, with greater lean body weight vs controls (P<.001). In both diabetic groups, absolute BMD and section modulus were higher compared with controls. However, after adjusting for total lean body weight, diabeticwomen on insulin had significantly lower BMD and section modulus. CONCLUSION: Adjusted for lean body weight, the BMD and bending strength in the femoral neck are significantly lower in insulin-treated diabeticwomen vs controls. This may represent altered adaptation of bone modeling and explain the higher fracture risk in patients with T2DM.
Authors: D A Nelson; T J Beck; G Wu; C E Lewis; T Bassford; J A Cauley; M S LeBoff; S B Going; Z Chen Journal: Osteoporos Int Date: 2010-08-25 Impact factor: 4.507
Authors: L Joseph Melton; Thomas J Beck; Shreyasee Amin; Sundeep Khosla; Sara J Achenbach; Ann L Oberg; B Lawrence Riggs Journal: Osteoporos Int Date: 2005-02-02 Impact factor: 4.507
Authors: Andrew J Burghardt; Ahi S Issever; Ann V Schwartz; Kevin A Davis; Umesh Masharani; Sharmila Majumdar; Thomas M Link Journal: J Clin Endocrinol Metab Date: 2010-08-18 Impact factor: 5.958
Authors: Elsa S Strotmeyer; Jane A Cauley; Ann V Schwartz; Michael C Nevitt; Helaine E Resnick; Joseph M Zmuda; Douglas C Bauer; Frances A Tylavsky; Nathalie de Rekeneire; Tamara B Harris; Anne B Newman Journal: J Bone Miner Res Date: 2004-03-15 Impact factor: 6.741
Authors: Florent Elefteriou; Jong Deok Ahn; Shu Takeda; Michael Starbuck; Xiangli Yang; Xiuyun Liu; Hisataka Kondo; William G Richards; Tony W Bannon; Masaki Noda; Karine Clement; Christian Vaisse; Gerard Karsenty Journal: Nature Date: 2005-02-20 Impact factor: 49.962
Authors: Federico Ponti; Sara Guerri; Claudia Sassi; Giuseppe Battista; Giuseppe Guglielmi; Alberto Bazzocchi Journal: Endocrine Date: 2017-03-14 Impact factor: 3.633
Authors: Abdulaziz F Hariri; Mohammad N Almatrafi; Aws B Zamka; Abdullah S Babaker; Tariq M Fallatah; Omar H Althouwaibi; Amre S Hamdi Journal: J Obes Date: 2019-04-22
Authors: Ling Oei; M Carola Zillikens; Abbas Dehghan; Gabriëlle H S Buitendijk; Martha C Castaño-Betancourt; Karol Estrada; Lisette Stolk; Edwin H G Oei; Joyce B J van Meurs; Joseph A M J L Janssen; Albert Hofman; Johannes P T M van Leeuwen; Jacqueline C M Witteman; Huibert A P Pols; André G Uitterlinden; Caroline C W Klaver; Oscar H Franco; Fernando Rivadeneira Journal: Diabetes Care Date: 2013-01-11 Impact factor: 19.112
Authors: Richard M Michelin; Layla Al-Nakkash; Tom L Broderick; Jeffrey H Plochocki Journal: Diabetes Metab Syndr Obes Date: 2016-03-15 Impact factor: 3.168